<DOC>
	<DOCNO>NCT00483054</DOCNO>
	<brief_summary>The randomize control trial conduct among antiretroviral naive co-infected HIV tuberculosis patient receive rifampicin-based antituberculous regimen fro least 4 week butt exceed 16 week enrolment . All patient receive backbone regimen stavudine ( 30 mg/40 mg twice daily ) + lamivudie 150 mg twice daily . They randomize receive nevirapine 400 mg/day twice daily vs efavirenz 600 mg/day bed time . All patient follow 144 week initiation antiviral therapy . The primary objective compare proportion patient achieve undetectable plasma HIV-1RNA &lt; 50 copies/ml week 48 . The previous report demonstrate standard dos nevirapine efavirenz coulde use among co-infected HIV tuberculosis patient receive rifampicin even though plasma level somewhat reduce rifampicin . However , randomize control trial compare two regimen . Thus , trial provide efficacy data two regimen .</brief_summary>
	<brief_title>Efavirenz-based Versus Nevirapine-based Antiretroviral Therapy Among HIV-infected Patients Receiving Rifampin</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Tuberculosis</mesh_term>
	<mesh_term>Nevirapine</mesh_term>
	<mesh_term>Stavudine</mesh_term>
	<mesh_term>Efavirenz</mesh_term>
	<mesh_term>Lamivudine</mesh_term>
	<mesh_term>Rifampin</mesh_term>
	<criteria>Age 1860 year Positive Serology HIV1 Na√Øve antiretroviral therapy Baseline CD4 cell count &lt; 250 cells/mm3 Diagnosed active tuberculosis clinical feature and/or positive acid fast stain and/or positive culture Received rifampicin least 4 week exceed 16 week prior enrollment Willing participate sign inform consent Aspartate transferase enzyme ( AST ) alanine transminase enzyme ( ALT ) &gt; 5 time upper limit total bilirubin &gt; 3 time upper limit serum creatinine ) &gt; 2 time upper limit pregnancy lactation receive immunosuppressive drug receive drug may drugdrug interaction nevirapine rifampicin chronic alcoholic drunken intravenous drug user Previously receive single dose nevirapine prevent mother child transmission positive serum cryptococcal antigen</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>June 2009</verification_date>
	<keyword>HIV</keyword>
	<keyword>tuberculosis</keyword>
	<keyword>efavirenz</keyword>
	<keyword>nevirapine</keyword>
	<keyword>rifampicin</keyword>
	<keyword>co-infected HIV tuberculosis patient</keyword>
</DOC>